501 related articles for article (PubMed ID: 27569399)
1. The Influenza Virus Polymerase Complex: An Update on Its Structure, Functions, and Significance for Antiviral Drug Design.
Stevaert A; Naesens L
Med Res Rev; 2016 Nov; 36(6):1127-1173. PubMed ID: 27569399
[TBL] [Abstract][Full Text] [Related]
2. Focusing on the Influenza Virus Polymerase Complex: Recent Progress in Drug Discovery and Assay Development.
Zhang J; Hu Y; Musharrafieh R; Yin H; Wang J
Curr Med Chem; 2019; 26(13):2243-2263. PubMed ID: 29984646
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel small-molecule compound targeting the influenza A virus polymerase PB1-PB2 interface.
Yuan S; Chu H; Ye J; Singh K; Ye Z; Zhao H; Kao RY; Chow BK; Zhou J; Zheng BJ
Antiviral Res; 2017 Jan; 137():58-66. PubMed ID: 27840201
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of an essential interaction between influenza polymerase and Pol II CTD.
Lukarska M; Fournier G; Pflug A; Resa-Infante P; Reich S; Naffakh N; Cusack S
Nature; 2017 Jan; 541(7635):117-121. PubMed ID: 28002402
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the polymerase PA(C)-PB1(N) complex from an avian influenza H5N1 virus.
He X; Zhou J; Bartlam M; Zhang R; Ma J; Lou Z; Li X; Li J; Joachimiak A; Zeng Z; Ge R; Rao Z; Liu Y
Nature; 2008 Aug; 454(7208):1123-6. PubMed ID: 18615018
[TBL] [Abstract][Full Text] [Related]
6. Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors.
Jones JC; Kumar G; Barman S; Najera I; White SW; Webby RJ; Govorkova EA
mBio; 2018 Apr; 9(2):. PubMed ID: 29691337
[TBL] [Abstract][Full Text] [Related]
7. The cap-binding site of influenza virus protein PB2 as a drug target.
Severin C; Rocha de Moura T; Liu Y; Li K; Zheng X; Luo M
Acta Crystallogr D Struct Biol; 2016 Feb; 72(Pt 2):245-53. PubMed ID: 26894672
[TBL] [Abstract][Full Text] [Related]
8. A peptide derived from the C-terminus of PB1 inhibits influenza virus replication by interfering with viral polymerase assembly.
Li C; Ba Q; Wu A; Zhang H; Deng T; Jiang T
FEBS J; 2013 Feb; 280(4):1139-49. PubMed ID: 23279951
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit.
Noshi T; Kitano M; Taniguchi K; Yamamoto A; Omoto S; Baba K; Hashimoto T; Ishida K; Kushima Y; Hattori K; Kawai M; Yoshida R; Kobayashi M; Yoshinaga T; Sato A; Okamatsu M; Sakoda Y; Kida H; Shishido T; Naito A
Antiviral Res; 2018 Dec; 160():109-117. PubMed ID: 30316915
[TBL] [Abstract][Full Text] [Related]
10. Temperature-Sensitive Mutants in the Influenza A Virus RNA Polymerase: Alterations in the PA Linker Reduce Nuclear Targeting of the PB1-PA Dimer and Result in Viral Attenuation.
Da Costa B; Sausset A; Munier S; Ghounaris A; Naffakh N; Le Goffic R; Delmas B
J Virol; 2015 Jun; 89(12):6376-90. PubMed ID: 25855727
[TBL] [Abstract][Full Text] [Related]
11. Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics.
Zhou Z; Liu T; Zhang J; Zhan P; Liu X
Drug Discov Today; 2018 Mar; 23(3):503-518. PubMed ID: 29339107
[TBL] [Abstract][Full Text] [Related]
12. Characteristic amino acid changes of influenza A(H1N1)pdm09 virus PA protein enhance A(H7N9) viral polymerase activity.
Liu J; Huang F; Zhang J; Tan L; Lu G; Zhang X; Zhang H
Virus Genes; 2016 Jun; 52(3):346-53. PubMed ID: 26980671
[TBL] [Abstract][Full Text] [Related]
13. A single amino acid mutation in the PA subunit of the influenza virus RNA polymerase inhibits endonucleolytic cleavage of capped RNAs.
Fodor E; Crow M; Mingay LJ; Deng T; Sharps J; Fechter P; Brownlee GG
J Virol; 2002 Sep; 76(18):8989-9001. PubMed ID: 12186883
[TBL] [Abstract][Full Text] [Related]
14. [Structural and Biochemical Analyses on the RNA-dependent RNA Polymerase of Influenza Virus for Development of Novel Anti-influenza Agents].
Hatakeyama D
Yakugaku Zasshi; 2017; 137(2):205-214. PubMed ID: 28154333
[TBL] [Abstract][Full Text] [Related]
15. Free energy calculations and binding analysis of two potential anti- influenza drugs with Polymerase basic protein-2 (PB2).
Lv HM; Guo XL; Gu RX; Wei DQ
Protein Pept Lett; 2011 Oct; 18(10):1002-9. PubMed ID: 21592080
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and antiviral activity of PB1 component of the influenza A RNA polymerase peptide fragments.
Matusevich OV; Egorov VV; Gluzdikov IA; Titov MI; Zarubaev VV; Shtro AA; Slita AV; Dukov MI; Shurygina AP; Smirnova TD; Kudryavtsev IV; Vasin AV; Kiselev OI
Antiviral Res; 2015 Jan; 113():4-10. PubMed ID: 25446335
[TBL] [Abstract][Full Text] [Related]
17. Peptide-Mediated Interference of PB2-eIF4G1 Interaction Inhibits Influenza A Viruses' Replication in Vitro and in Vivo.
Yuan S; Chu H; Ye J; Hu M; Singh K; Chow BK; Zhou J; Zheng BJ
ACS Infect Dis; 2016 Jul; 2(7):471-7. PubMed ID: 27626099
[TBL] [Abstract][Full Text] [Related]
18. The interaction of cellular protein ANP32A with influenza A virus polymerase component PB2 promotes vRNA synthesis.
Wei X; Liu Z; Wang J; Yang R; Yang J; Guo Y; Tan H; Chen H; Liu Q; Liu L
Arch Virol; 2019 Mar; 164(3):787-798. PubMed ID: 30666459
[TBL] [Abstract][Full Text] [Related]
19. The structural basis for an essential subunit interaction in influenza virus RNA polymerase.
Obayashi E; Yoshida H; Kawai F; Shibayama N; Kawaguchi A; Nagata K; Tame JR; Park SY
Nature; 2008 Aug; 454(7208):1127-31. PubMed ID: 18660801
[TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of avian influenza viral polymerase containing PA or PB2 subunit from human influenza A virus.
Pham PTV; Turan K; Nagata K; Kawaguchi A
Microbes Infect; 2018; 20(6):353-359. PubMed ID: 29729434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
